LENSAR Inc (LNSR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
LENSAR Inc stock (LNSR) is currently trading at $5.58. LENSAR Inc PS ratio (Price-to-Sales) is 1.23. Analyst consensus price target for LNSR is $12.50. WallStSmart rates LNSR as Sell.
- LNSR PE ratio analysis and historical PE chart
- LNSR PS ratio (Price-to-Sales) history and trend
- LNSR intrinsic value — DCF, Graham Number, EPV models
- LNSR stock price prediction 2025 2026 2027 2028 2029 2030
- LNSR fair value vs current price
- LNSR insider transactions and insider buying
- Is LNSR undervalued or overvalued?
- LENSAR Inc financial analysis — revenue, earnings, cash flow
- LNSR Piotroski F-Score and Altman Z-Score
- LNSR analyst price target and Smart Rating
LENSAR Inc
📊 No data available
Try selecting a different time range
Smart Analysis
LENSAR Inc (LNSR) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
LENSAR Inc (LNSR) Key Strengths (1)
Paying $1.23 for every $1 of annual revenue
Supporting Valuation Data
LENSAR Inc (LNSR) Areas to Watch (7)
Company is destroying shareholder value
Losing money on operations
Company is losing money with a negative profit margin
Micro-cap company with very limited liquidity and high volatility
Modest revenue growth at 5.70%
Fairly priced relative to book value
Moderate institutional interest at 49.60%
LENSAR Inc (LNSR) Detailed Analysis Report
Overall Assessment
This company scores 28/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 1 register as strengths (avg 8.0/10) while 7 fall into concern territory (avg 2.7/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales. Valuation metrics including Price/Sales (1.23) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Profit Margin. Some valuation metrics including Price/Book (2.17) suggest expensive pricing. Growth concerns include Revenue Growth at 5.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -422.30%, Operating Margin at -16.10%, Profit Margin at -87.10%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -422.30% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 5.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
LNSR Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
LNSR's Price-to-Sales ratio of 1.23x trades 44% below its historical average of 2.2x (21th percentile). The current valuation is 70% below its historical high of 4.09x set in Feb 2021, and 68% above its historical low of 0.73x in Oct 2023. Over the past 12 months, the PS ratio has compressed from ~3.2x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for LENSAR Inc (LNSR) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
LENSAR Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 59M with 6% growth year-over-year. The company is currently unprofitable, posting a -87.1% profit margin.
Key Findings
The company is unprofitable with a -87.1% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -4M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact LENSAR Inc.
Bottom Line
LENSAR Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About LENSAR Inc(LNSR)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
LENSAR, Inc., a commercial stage medical device company, is focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company is headquartered in Orlando, Florida.